Many studies have established the dominant involvement of PGC-1α in mitobiogenesis, and the influence of PGC-1α-related mitobiogenesis has also been connected to a number of illnesses, including metabolic disease, cardiomyopathy, neurodegenerative disease, cancer, and kidney disease [57–63]. Here, PPARGC1A is linked to cardiomyopathy.